IRIS
VITIELLO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.230
AS - Asia 696
EU - Europa 696
SA - Sud America 103
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 12
OC - Oceania 1
Totale 2.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.192
RU - Federazione Russa 420
SG - Singapore 275
CN - Cina 170
IT - Italia 135
BR - Brasile 82
BD - Bangladesh 71
HK - Hong Kong 52
VN - Vietnam 51
DE - Germania 30
FR - Francia 28
GB - Regno Unito 28
CA - Canada 22
IN - India 22
JP - Giappone 15
NL - Olanda 12
AR - Argentina 9
MX - Messico 9
PL - Polonia 9
ES - Italia 6
FI - Finlandia 6
SE - Svezia 6
SA - Arabia Saudita 5
ID - Indonesia 4
LT - Lituania 4
MY - Malesia 4
TR - Turchia 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IQ - Iraq 3
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
VE - Venezuela 3
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
IR - Iran 2
JM - Giamaica 2
NI - Nicaragua 2
SV - El Salvador 2
TW - Taiwan 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MV - Maldive 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 2.738
Salva come PNG Salva come JPEG
Città #
Dallas 734
Singapore 186
Moscow 75
Ashburn 65
Hong Kong 50
Beijing 46
San Jose 42
New York 38
Los Angeles 31
Council Bluffs 24
Santa Clara 22
Ho Chi Minh City 19
Milan 17
Munich 17
Orem 15
Rome 15
Lauterbourg 14
Hanoi 13
São Paulo 12
Tokyo 12
Chicago 9
Montreal 9
Hefei 8
London 8
Naples 8
Poplar 8
Brooklyn 7
Manchester 7
Warsaw 7
Bacoli 6
Denver 6
Frankfurt am Main 6
Guangzhou 6
Phoenix 6
Secaucus 6
Shanghai 6
Stockholm 6
Toronto 6
Atlanta 5
Cesano Boscone 5
Chennai 5
North Bergen 5
West Palm Beach 5
Bari 4
Boston 4
Dhaka 4
Mexico City 4
Monza 4
Mumbai 4
Newark 4
Omaha 4
Riyadh 4
Tianjin 4
Amsterdam 3
Belo Horizonte 3
Boardman 3
Da Nang 3
Helsinki 3
Houston 3
Johannesburg 3
Milwaukee 3
Nanning 3
Porto Alegre 3
Querétaro 3
San Francisco 3
Shenzhen 3
Agadir 2
Ankara 2
Biên Hòa 2
Brescia 2
Brussels 2
Buffalo 2
Cape Coral 2
Charlotte 2
Chengdu 2
Cleveland 2
Colombo 2
Duque de Caxias 2
Forcalquier 2
Formosa 2
Fortaleza 2
Genoa 2
Guarulhos 2
Helena 2
Ipoh 2
Islington 2
Jinhua 2
Kathmandu 2
Kolkata 2
Lancaster 2
Lappeenranta 2
Managua 2
Marseille 2
New Delhi 2
Nuremberg 2
Oklahoma City 2
Padua 2
Palermo 2
Pasadena 2
Pelotas 2
Totale 1.744
Salva come PNG Salva come JPEG
Nome #
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab 437
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study 422
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma 148
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study 141
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 135
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study 123
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 122
Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents 122
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 116
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 115
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 111
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 109
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma 98
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 95
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 89
Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting 85
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications 83
Anti-HER2 therapies in biliary tract cancers: A meta-analysis on disease location, HER2 status, and survival outcomes 81
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment 76
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 74
Unleashing precision: A review of targeted approaches in pleural mesothelioma 7
null 7
Immunotherapy in small bowel adenocarcinoma: a potential role? 5
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience 4
Totale 2.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 1 6 5
2024/2025117 6 0 0 3 8 10 11 16 5 5 10 43
2025/20262.515 114 390 489 231 176 79 105 159 406 92 149 125
2026/2027161 89 72 0 0 0 0 0 0 0 0 0 0
Totale 2.805